| Year |
Citation |
Score |
| 2019 |
Ioannou GN, Beste LA, Green PK, Singal AG, Tapper EB, Waljee AK, Sterling RK, Feld JJ, Kaplan DE, Taddei TH, Berry K. Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores. Gastroenterology. PMID 31356807 DOI: 10.1053/J.Gastro.2019.07.033 |
0.342 |
|
| 2019 |
Ioannou GN, Green P, Kerr KF, Berry K. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification. Journal of Hepatology. PMID 31145929 DOI: 10.1016/J.Jhep.2019.05.008 |
0.319 |
|
| 2018 |
Ioannou GN, Green PK, Beste LA, Mun EJ, Kerr KF, Berry K. Development of Models Estimating the Risk of Hepatocellular Carcinoma After Antiviral Treatment for Hepatitis C. Journal of Hepatology. PMID 30138686 DOI: 10.1016/J.Jhep.2018.07.024 |
0.353 |
|
| 2018 |
Moon AM, Weiss NS, Beste LA, Su F, Ho SB, Jin GY, Lowy E, Berry K, Ioannou GN. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-related Mortality in Patients with Cirrhosis. Gastroenterology. PMID 29981779 DOI: 10.1053/J.Gastro.2018.06.079 |
0.351 |
|
| 2017 |
Ioannou GN, Green PK, Berry K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma. Journal of Hepatology. PMID 28887168 DOI: 10.1016/J.Jhep.2017.08.030 |
0.346 |
|
| 2017 |
Beste LA, Green PK, Berry K, Kogut MJ, Allison SK, Ioannou GN. Effectiveness of hepatitis c antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma. Journal of Hepatology. PMID 28267622 DOI: 10.1016/J.Jhep.2017.02.027 |
0.352 |
|
| 2017 |
Su F, Beste LA, Green PK, Berry K, Ioannou GN. Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients. European Journal of Gastroenterology & Hepatology. PMID 28195877 DOI: 10.1097/Meg.0000000000000858 |
0.32 |
|
| 2016 |
Tsui JI, Williams EC, Green PK, Berry K, Su F, Ioannou GN. Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents. Drug and Alcohol Dependence. 169: 101-109. PMID 27810652 DOI: 10.1016/J.Drugalcdep.2016.10.021 |
0.3 |
|
| 2016 |
Su F, Green PK, Berry K, Ioannou GN. The association between race/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection. Hepatology (Baltimore, Md.). PMID 27775854 DOI: 10.1002/Hep.28901 |
0.315 |
|
| 2016 |
Ioannou GN, Beste LA, Chang MF, Green PK, Lowey E, Tsui JI, Su F, Berry K. Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Healthcare System. Gastroenterology. PMID 27267053 DOI: 10.1053/J.Gastro.2016.05.049 |
0.326 |
|
| 2016 |
Berry K, Lerrigo R, Liou IW, Ioannou GN. Association Between Transjugular Intrahepatic Portosystemic Shunt and Survival in Patients With Cirrhosis Clinical Gastroenterology and Hepatology. 14: 118-123. DOI: 10.1016/J.Cgh.2015.06.042 |
0.336 |
|
| 2015 |
Su F, Yu L, Berry K, Liou IW, Landis CS, Rayhill SC, Reyes JD, Ioannou GN. Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes and transplant-related survival benefit. Gastroenterology. PMID 26522262 DOI: 10.1053/J.Gastro.2015.10.043 |
0.318 |
|
| 2015 |
Berry K, Taylor J, Liou IW, Ioannou GN. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 13: 585-93. PMID 25459555 DOI: 10.1016/J.Cgh.2014.10.010 |
0.356 |
|
| 2015 |
Berry K, Ioannou GN. Comparison of Liver Transplant-Related Survival Benefit in Patients with Versus Without Hepatocellular Carcinoma in the United States Gastroenterology. 149: 669-680. DOI: 10.1053/J.Gastro.2015.05.025 |
0.358 |
|
| 2014 |
Barocas DA, Bensink ME, Berry K, Musa Z, Bodnar C, Dann R, Ramsey SD. Economic evaluation of diagnostic localization following biochemical prostate cancer recurrence. International Journal of Technology Assessment in Health Care. 30: 345-53. PMID 25399914 DOI: 10.1017/S0266462314000476 |
0.311 |
|
| 2014 |
Burnett-Hartman AN, Bensink ME, Berry K, Mummy DG, Warren-Mears V, Korenbrot C, Ramsey SD. Access to the Indian health service care system is not associated with early enrollment in medicaid for American Indian and Alaska Natives with cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 362-4. PMID 24296857 DOI: 10.1158/1055-9965.Epi-13-1099 |
0.305 |
|
| 2013 |
Berry K, Ioannou GN. Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 19: 634-45. PMID 23536495 DOI: 10.1002/Lt.23652 |
0.322 |
|
| 2012 |
Afzali A, Berry K, Ioannou GN. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 18: 29-37. PMID 21932374 DOI: 10.1002/Lt.22435 |
0.352 |
|
| 2012 |
Berry K, Bensink ME, Musa Z, Shankaran V, Lin EH, Ladabaum U, Bodnar C, Birt M, Ramsey SD. Cost-effectiveness of biomarker-directed bevacizumab for first-line therapy of persons with metastatic colorectal cancer. Journal of Clinical Oncology. 30: 6077-6077. DOI: 10.1200/Jco.2012.30.15_Suppl.6077 |
0.336 |
|
| 2011 |
Afzali A, Berry K, Mandelson M, Ioannou G. Survival in Nonalcoholic Steatohepatitis and Cryptogenic Cirrhosis After Liver Transplantation: An Analysis of the Unos Database Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)63994-2 |
0.302 |
|
| 2003 |
Ramsey SD, Mandelson MT, Berry K, Etzioni R, Harrison R. Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology. 125: 1645-50. PMID 14724816 DOI: 10.1053/J.Gastro.2003.09.032 |
0.31 |
|
| 2001 |
Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Annals of Internal Medicine. 135: 577-88. PMID 11601929 DOI: 10.7326/0003-4819-135-8_Part_1-200110160-00008 |
0.305 |
|
| 2001 |
Etzioni R, Ramsey SD, Berry K, Brown M. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study. Health Economics. 10: 245-56. PMID 11288190 DOI: 10.1002/Hec.580 |
0.304 |
|
| Show low-probability matches. |